Two Sigma Advisers LP decreased its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 33.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,609,300 shares of the company's stock after selling 808,500 shares during the quarter. Two Sigma Advisers LP owned approximately 0.79% of DocuSign worth $99,921,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign during the third quarter valued at about $28,000. Mather Group LLC. boosted its position in DocuSign by 4,338.5% during the 2nd quarter. Mather Group LLC. now owns 577 shares of the company's stock worth $31,000 after buying an additional 564 shares during the period. Brooklyn Investment Group bought a new stake in DocuSign during the 3rd quarter worth approximately $33,000. Reston Wealth Management LLC acquired a new position in DocuSign in the 3rd quarter valued at approximately $47,000. Finally, nVerses Capital LLC acquired a new position in shares of DocuSign during the second quarter worth $48,000. Institutional investors own 77.64% of the company's stock.
NASDAQ DOCU opened at $83.68 on Friday. The company has a fifty day moving average price of $73.75 and a 200-day moving average price of $61.68. The firm has a market cap of $16.98 billion, a price-to-earnings ratio of 17.65, a PEG ratio of 8.33 and a beta of 0.92. DocuSign, Inc. has a 1 year low of $44.34 and a 1 year high of $86.75.
DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.80 by $0.17. The firm had revenue of $736.03 million for the quarter, compared to analysts' expectations of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.09 EPS. On average, research analysts anticipate that DocuSign, Inc. will post 1.03 EPS for the current fiscal year.
In related news, insider Robert Chatwani sold 14,799 shares of the company's stock in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total value of $820,752.54. Following the transaction, the insider now owns 70,748 shares in the company, valued at approximately $3,923,684.08. This represents a 17.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,648 shares of the company's stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total transaction of $477,770.56. Following the sale, the chief executive officer now directly owns 115,589 shares in the company, valued at approximately $7,220,844.83. This trade represents a 6.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 69,596 shares of company stock valued at $4,441,529. Insiders own 1.66% of the company's stock.
A number of research firms have weighed in on DOCU. JMP Securities increased their target price on shares of DocuSign from $84.00 to $108.00 and gave the company a "market outperform" rating in a research report on Friday, November 22nd. JPMorgan Chase & Co. lifted their price objective on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research report on Tuesday. Robert W. Baird upped their target price on DocuSign from $55.00 to $59.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Citigroup lifted their target price on DocuSign from $86.00 to $87.00 and gave the stock a "buy" rating in a report on Friday, September 6th. Finally, Jefferies Financial Group increased their price target on DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a report on Tuesday. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, DocuSign presently has a consensus rating of "Hold" and a consensus price target of $70.73.
Read Our Latest Stock Report on DOCU
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.